17
Views
4
CrossRef citations to date
0
Altmetric
CASE REPORT

Successful treatment of chronic lupus myocarditis with prednisolone and mizoribine

, , , , , , , , , , , , & show all
Pages 606-610 | Received 17 Mar 2010, Accepted 31 May 2010, Published online: 02 Jan 2014

References

  • Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med. 2002;113:419–23.
  • Chan YK, Li EK, Tam LS, Chow LT, Ng HK. Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scand J Rheumatol. 2003;32:306–8.
  • Gottenberg JE, Roux S, Assayag P, Clerc D, Mariette X. Specific cardiomyopathy in lupus patients: report of three cases. Joint Bone Spine. 2004;71:66–9.
  • Brigden W, Bywaters EG, Lessof MH, Ross IP. The heart in systemic lupus erythematosus. Br Heart J. 1960;22:1–16.
  • Bidani AK, Roberts JL, Schwartz MM, Lewis E.T. Immunopa-thology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med. 1980;69:849–58.
  • Bulkley BH, Roberts WC. The heart in systemic lupus erythe-matosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med. 1975;58:243–64.
  • Logar D, Kveder T, Rozman B, Dobovisek J. Possible association between anti-Ro antibodies and myocarditis or cardiac conduc-tion defects in adults with systemic lupus erythematosus. Ann Rheum Dis. 1990;49:627–9.
  • Vogel-Claussen J, Rochitte CE, Wu KC, Kamel IR, Foo TK, Lima JA, et al. Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics. 2006;26:795–810.
  • Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasi-adis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250–8.
  • Naarendorp M, Kerr LD, Khan AS, Ornstein MH. Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J Rheumatol. 1999;26:2257–60.
  • Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H. Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun. 2000;274: 87–92.
  • Chung JW, Joe DY, Park HJ, Kim HA, Park HS, Suh CH. Clinical characteristics of lupus myocarditis in Korea. Rheumatol Int. 2008;28:275–80.
  • Busteed S, Sparrow P, Molloy C, Molloy MG. Myocarditis as a prognostic indicator in systemic lupus erythematosus. Postgrad Med J. 2004;80:366–7.
  • Sun V, Varma S, Joshi K, Malhotra P, Kumari S, Jain S. Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy. Rheumatol Int 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.